Barbital | |
---|---|
Salts [] | |
---|---|
Sodium | |
Hydrochloride | |
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 184.19 g/mol [1] |
Predicted LogP | 0.6 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C8H12N2O3 [1] |
IUPAC name | 5,5-diethyl-1,3-diazinane-2,4,6-trione [1] |
SMILES | CCC1(C(=O)NC(=O)NC1=O)CC [1] |
InChI | InChI=1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13) [1] |
InChIKey | FTOAOBMCPZCFFF-UHFFFAOYSA-N [1] |
Dosing [] | |
---|---|
Elimination half-life | 30.3 (± 3.2) hours |
Barbital
Barbital (also known as Barbitone, 5,5-Diethylbarbituric acid, Ethylbarbital, Diemal, Diethylmalonylurea, DEBA, 5,5-diethylpyrimidine-2,4,6(1H,3H,5H)-trione, 200-331-2, Veronal or Malonal) is a
Chemistry
Salts []
Stereochemistry []
Barbital is a achiral mixture
Legal status
- Brazil: Barbital is a B1 substance.[3]
- Canada: Barbital is a Schedule IV substance.
- United States: Barbital is a Schedule I under the "Controlled Substances Act (CSA)".
- Germany: Barbital is a Anlage III substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 2294, Barbital. Accessed July 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/2294
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Barbital. UNII: 5WZ53ENE2P. Global Substance Registration System. Accessed July 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/5WZ53ENE2P
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed July 13, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992